MAPT and Alzheimer disease: Alzheimer’s disease (AD) is the most common neurodegenerative disorder and some studies have demonstrated that AD patients predominantly present a lobar distribution of cerebral microbleeds, potentially correlated with cerebrospinal fluid levels of amyloid-beta and phosphorylated tau 181 protein [27].